NCT02306161-D5
Dataset Information
Dataset ID: NCT02306161-D5
PubMed ID (PMID):
Publication Title:
Randomized Phase 3 Trial of Ganitumab Added to Interval Compressed Chemotherapy for Patients with Newly Diagnosed Metastatic Ewing Sarcoma: A Report from the Children’s Oncology Group
Description of Dataset:
D5: There are 5 datasets associated with the PMID 36669140: NCT02306161-D1 through NCT02306161-D5. This dataset, NCT02306161-D5, provides the information on the crossover effect on OS in the supplemental materials. There is one row per patient and time-period prior to the discontinuation of ganitumab and after, if applicable, to reflect the time at risk before and after, discontinuation.
Data Dictionary:
Submission includes new data:
Yes
Trials Linked to Dataset
| NCT Trial Number | Disease Type |
|---|---|
| NCT02306161 |
Accessibility | Disclaimer | FOIA | HHS Vulnerability Disclosure | Privacy & Security
U.S. Department of Health and Human Services | National Institutes of Health | National Cancer Institute | USA.gov
NIH…Turning Discovery Into Health®